Literature DB >> 1085710

Detection of T-precursor cells in human bone marrow and foetal liver.

K W Pyke, E W Gelfand.   

Abstract

Human lymphoid cells that have been incubated with conditioned medium from confluent monolayers of human thymic epithelium (HTCM) show an increase in cells forming rosettes with sheep erythrocytes at 4 degrees C (E-rosettes). Those cells demonstrating this in vitro conversion have been interpreted to be T-cell precursors. Separation of human bone marrow cells on discontinuous bovine serum albumin (BSA) gradients, and on a single-step 23% BSA gradient showed enrichment of these T-precursor cells, not only in bone marrow, but also in human foetal liver cells. Bone marrow precursor cells from a patient with Wiskott-Aldrich syndrome (T-cell deficiency) showed a normal in vitro response to HTCM, but no response was seen in cells from a patient with severe combined immunodeficiency disease.

Entities:  

Mesh:

Year:  1976        PMID: 1085710     DOI: 10.1111/j.1432-0436.1976.tb00914.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  4 in total

1.  Role of adenosine deaminase in the early stages of precursor T cell maturation.

Authors:  A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

2.  Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.

Authors:  E W Gelfand; H M Dosch; W D Biggar; I H Fox
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

3.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

4.  The effects of thymic epithelial monolayer-conditioned medium on suppressor cell function following chemotherapy in pediatric patients.

Authors:  M S Borzy; D Ridgway
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.